HomeHealth Sciences Journalvol. 7 no. 1 (2018)

The role of bariatric and metabolic surgery on mildly obese diabetic patients

Katherine G. Ordinario | Emmanuel S. Astudillo



Introduction Bariatric surgery has been incorporated in the care of diabetic patients with a body mass index greater than 35 kg/m², however a segment of the diabetic population has a body mass index 30 to < 35 kg/m² that compared bariatric surgery with non-surgical management were considered in this study. The primary outcomes of interest were remission of diabetes mellitus, changes in body mass index, glycosylated hemoglobin and fasting blood sugar levels and in weight. The odds ratio was the primary measure of treatment effect; 95% confidence intervals were utilized. Heterogeneity were assessed by Q-square (v2 ) and I-square statistics (I²). Meta-analysis with forest plot was performed using Review Manager Version 5.3. Results Remission of diabetes was achieved in 69 out of 94 patients (73%) in four studies included in the analysis (OR = 79.07, 95% CI 12.36, 506.3). Decrease in glycosylated hemoglobin, fasting blood sugar, body mass index, weight, total cholesterol, triglycerides and increase in HDL was greater in the surgical arms of all the included studies. Conclusion Bariatric surgery is a rapid, effective and sustainable treatment option for the resolution of type 2 diabetes mellitus even among mildly obese patients. It is effective in improving or resolving diabetes- and obesity-related diseases such as dyslipidemia.


  1. World Health Organization. Global Report on Diabetes. Available from: http://www.bing.com/cr?IG=A0343BAEE7A349AE91lEBCI5245AE8EO&CID=336ABOEE9FB6E8FO1EFA1AE8FD6F46&rd=l&h=2CPx8EQVDBwTrCLqMmI1YMTDWoMADYPyQmYONJMms&v=1&r=http3a2f2fwho.int2fdiabetes2fglobal-report2fen2f&p=DevEx,5066.l. [AccessedJun 18, 2017).
  2. Sugerman HJ. The ASBS Consensus Conference on the state of bariatric surgery and morbid obesity: Health implications for patients, health professionals and third-party payors. Surgery for Obesity and Related Diseases 2005; 1(2): 105. DOl: 10.1016/j.soard.2005.02.020.
  3. 3 Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys. lnt J Clin Pract 2007: 61(5): 737-47. DOl: 10.111l/j.1742-124l.2007.01336.x.
  4. 4 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2005: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-3l.
  5. 5 Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: A randomized controlled trial. Diab Res Clin Pract 20l3; 101(1): 50-6. DOl: 10.1016/j.diabres.2013.04.005.
  6. Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: A randomized controlled trial. The Lancet Diab Endocrinol 2014; 2(7): 545-52. DOI: 10.1016/s22l3-8587(14)70066-x.
  7. Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bar iatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do not meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg 2014; 260(4): 617-24. DOl: 10.10971 sla.0000000000000919.
  8. Scopinaro N, Adami GF, Papadia FS, et al. Effects of gastric bypass on type 2 diabetes in patients with BMl 30 to 35. Obesity Surg 2014; 24(7): 1036-43. DOl: 1O.1007/s11695-014-1206-1.
  9. Azim S, Kashyap SR. Bariatric surgery. Endocrinol Metab Clin North Am 2016; 45(4): 905-2l. DOl: 1O.1016/j.ecI.2016.06.011.
  10. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: Clinical outcomes and mechanisms of action. Ann Rev Med 2010; 61(1): 393-41l. DOl: 10.1146/annurev. med.051308.105148.
  11. Papamargaritis D, Panteliou E, Miras AD, Roux CWo Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery. Curr Atheroscl Rep 2012; 14(6): 616-23. DOl: 10.10071 s11883-012-0283-7.
  12. Liou AP, Paziuk M, Luevano J, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine 2013; 5(178). DOl: 10. 1126/scitranslmed.3005687.
  13. Kasper DL. Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology. (nd).
  14. Muller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in non-severely obese patients. Ann Surg 2015; 261(3): 421-9. DOl: 10.1097/s1a.00000000000010l4.
  15. Courcoulas AP, Belle SH, Neiberg RH, et al. Three- year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment. JAM A Surgery 2015; 150(10): 93l. DOl: 10.10011/jamasurg.2015.1534.